Avinash Nangia

This inventor holds 24 USPTO granted patents and 2 published patent applications, plus 5 CIPO patents and 4 EPO patents, primarily in Pharmaceutical Formulation. Top assignees: Andrx Pharmaceuticals, Inc., Watson Pharmaceuticals, Inc., Actavis, Inc.. Active years: 2003-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Avinash Nangia. Retrieved from https://idiyas.com/inventor/avinash-nangia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 (Patent Applications = 2)

% Patents Active = 37.5

CIPO Patents = 5 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 3)

Average Co-Inventor Count = 3.8

ph-index = 5

Forward Citations = 129(Granted Patents)

Location History:

Weston, FL (US) (2003 - 2014)
Lincoln, RI (US) (2011 - 2015)

Company Filing History:

13 out of 58

Andrx Pharmaceuticals, Inc.

patents

5 out of 27

Watson Pharmaceuticals, Inc.

Takeda Pharmaceutical Company Limited

patents

5. 1 out of 8

Andrx Corporation, Inc.

7. 2 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 2003-2015

Loading Chart...

Areas of Expertise:

Biguanide

Thiazolidinedione

Controlled Release

Oral Dosage

Extended Release

Venlafaxine

Antihistamine

Pharmaceutical Composition

Pravastatin

Drug Loaded Cores

Sodium Valproate

Immersion Testing

24 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9060941 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2015-06-23),

2. 8747898 - Controlled release oral dosage form (2014-06-10),

3. 8668932 - Extended release venlafaxine formulation (2014-03-11),

4. 8668931 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2014-03-11),

5. 8628797 - Oral extended-release composition (2014-01-14),

6. 8545880 - Controlled release oral dosage form (2013-10-01),

7. 8529946 - Rapidly disintegrating antihistamine formulation (2013-09-10),

8. 8470368 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2013-06-25),

9. 8309125 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2012-11-13),

10. 8084058 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2011-12-27),

11. 7959946 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2011-06-14),

12. 7931915 - Extended release venlafaxine formulation (2011-04-26),

13. 7790200 - Formulation and process for drug loaded cores (2010-09-07),

14. 7785627 - Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative (2010-08-31),

15. 7771750 - Controlled release oral dosage form (2010-08-10),

Title: The Innovative Journey of Avinash Nangia

Introduction:

Avinash Nangia, a visionary inventor based in Weston, FL (US), has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents:

Avinash Nangia holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights:

With a background in engineering and a passion for problem-solving, Avinash Nangia has led successful projects that have revolutionized industries and improved the lives of many.

Collaborations:

Throughout his career, Avinash Nangia has collaborated with leading research institutions, universities, and tech companies to bring his ideas to life and create tangible solutions for complex challenges.

Conclusion:

Inventor Avinash Nangia's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true pioneer in the world of technology.

Profile summary based on public USPTO records.